Code
MOG-MGMX-01CX
Test
Active-Compendium
81287
Clinical
Oncology,Pathology
FFPE solid tumor tissue: Paraffin block is preferred. Alternatively, send 1 H&E slide plus 5-10 unstained slides cut at 5 or more microns. Please use positively-charged slides and 10% NBF fixative. Do not use zinc fixatives. A minimum of 40% tumor is required. If the tumor cannot be enriched to at least 40%, then testing will not be performed.
Flag Active
True
Orderable Test Description
<p>Bisulfite modification of tumor DNA and real-time PCR are used to quantify CpG methylation within the MGMT gene promoter. Please note detection of MGMT promoter methylation analysis is qualitative.</p>
<p> </p>
<p>As of May 12, 2025, this test serves as replacement for the following test(s) that are no longer offered:</p>
<ul>
<li>Brain NGS Fusion Panel</li>
</ul>
<p> </p>
<p>As of May 12, 2025, this test serves as replacement for the following test(s) that are no longer offered:</p>
<ul>
<li>Brain NGS Fusion Panel</li>
</ul>
Orderable Turn Around Time
10 Days
Keywords
Orderable Biomarkers
NY Approved
True
Orderable Biomarkers JSON
{"DNA Sequencing": {"Promoter Methylation": ["MGMT"]}}
Keywords string
mgmt, promoter, methylation, Brain NGS Fusion Panel MGMT Promoter Methylation Analysis
Title URL
mgmt-promoter-methylation-analysis
Storage and transportation
Use cold pack for transport, making sure cold pack is not in direct contact with specimen. NYS clients please provide date and time of Collection.